ArticleInterface focus2025
Why population heterogeneity matters for modelling infectious diseases.
Article in Interface focus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Identification of clinical phenotypes and prediction model for the mixed-infection phenotype of pediatric community-acquired pneumonia based on unsupervised machine learning.Frontiers in pediatrics · 2026Article
- Why population heterogeneity matters for modelling infectious diseases.Interface focus · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic highlighted significant differences in infectious disease burden among sociodemographic groups in the United States, underscoring the need for modelling approaches that can capture the complex dynamics driving these heterogeneities. Specifically, variation in case incidence, mortality and disease burden has been observed across subpopulations stratified by race, ethnicity, sex, age and geographic region. Accurately incorporating fine-grained sociodemographic attributes into infectious disease models remains challenging due to complex correlations among individual characteristics. Additionally, accurately modelling transmission while accounting for exposure differences among population strata requires a detailed understanding of transmission risk across interaction settings. We address these challenges by incorporating drivers of exposure risk and detailed sociodemographic data into EpiCast-a large-scale agent-based model of respiratory pathogen spread in the United States. Using this model, we demonstrate how differences in the rate of infections between key demographic groups emerge in households, workplaces and schools. Our findings show that embedding fine-grained population heterogeneity into infectious disease models can reveal uneven outcomes in predicted disease burden among racial groups, driven by factors such as household size and workplace exposure risk. This study demonstrates the potential of detailed models of infectious disease spread to inform policy intervention design for future pandemics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.